Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 27;26(7):3067.
doi: 10.3390/ijms26073067.

Analysis of FBN1, TGFβ2, TGFβR1 and TGFβR2 mRNA as Key Molecular Mechanisms in the Damage of Aortic Aneurysm and Dissection in Marfan Syndrome

María Elena Soto  1   2 , Myrlene Rodríguez-Brito  3 , Israel Pérez-Torres  4 , Valentín Herrera-Alarcon  3 , Humberto Martínez-Hernández  3 , Iván Hernández  3 , Vicente Castrejón-Téllez  5 , Betsy Anaid Peña-Ocaña  6   7 , Edith Alvarez-Leon  8 , Linaloe Manzano-Pech  4 , Ricardo Gamboa  5 , Giovanny Fuentevilla-Alvarez  9 , Claudia Huesca-Gómez  5
Affiliations

Analysis of FBN1, TGFβ2, TGFβR1 and TGFβR2 mRNA as Key Molecular Mechanisms in the Damage of Aortic Aneurysm and Dissection in Marfan Syndrome

María Elena Soto et al. Int J Mol Sci. .

Abstract

Marfan syndrome (MFS) is an inherited connective tissue disorder, with aortic root aneurysm and/or dissection being the most severe and life-threatening complication. These conditions have been linked to pathogenic variants in the FBN1 gene and dysregulated TGFβ signaling. Our objective was to evaluate the mRNA expression of FBN1, TGFBR1, TGFBR2, and TGFB2 in aortic tissue from MFS patients undergoing surgery for aortic dilation. This prospective study (2014-2023) included 20 MFS patients diagnosed according to the 2010 Ghent criteria, who underwent surgery for aneurysm or dissection based on Heart Team recommendations, along with 20 non-MFS controls. RNA was extracted, and mRNA levels were quantified using RT-qPCR. Patients with dissection showed significantly higher FBN1 mRNA levels [79 (48.1-110.1)] compared to controls [37.2 (25.1-79)] (p = 0.03). Conversely, TGFB2 expression was significantly lower in MFS patients [12.17 (6.54-24.70)] than in controls [44.29 (25.85-85.36)] (p = 0.029). A positive correlation was observed between higher FBN1 expression and a larger sinotubular junction diameter (r = 0.42, p = 0.07), while increased FBN1 expression was particularly evident in MFS patients with dissection. Additionally, TGFB2 expression showed an inverse correlation with ascending aortic diameter (r = 0.53, p = 0.01). In aortic tissue, we found decreased TGFB2 and receptor levels alongside increased FBN1 mRNA levels. These molecular alterations may reflect compensatory mechanisms in response to tissue damage caused by mechanical stress, leading to dysregulation of physiological signaling pathways and ultimately contributing to aortic dilation in MFS.

Keywords: FBN1; Marfan syndrome; TGFβ2; TGFβR1; TGFβR2; aortic dissection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Histopathology of aortic aneurysms and dissections in three MFS patients. (A) A 28-year-old male with a giant ascending aorta aneurysm, showing rupture of elastic fibers in the adventitia with minimal inflammatory infiltrate hematoxylin–eosin. (B) A 36-year-old female with Stanford type A aortic dissection extending to the supra-aortic trunks, Weigert’s method. (C) A 33-year-old male with DeBakey type II aortic dissection, showing destruction of elastic fibers with cystic medial necrosis Masson’s trichrome staining.
Figure 2
Figure 2
Expression levels of (A) FBN1, (B) TGFβ2, (C) TGFβR1 and (D) TGβR2 mRNA, normalized with 18 s mRNA, in the study groups.
See this image and copyright information in PMC

References

    1. Dietz H.C., Cutting C.R., Pyeritz R.E., Maslen C.L., Sakai L.Y., Corson G.M., Puffenberger E.G., Hamosh A., Nanthakumar E.J., Curristin S.M., et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–339. doi: 10.1038/352337a0. - DOI - PubMed
    1. Faivre L.C.B.G., Collod-Beroud G., Loeys B.L., Child A., Binquet C., Gautier E., Callewaert B., Arbustini E., Mayer K., Arslan-Kirchner M., et al. Effect of Mutation Type and Location on Clinical Outcome in 1,013 Probands with Marfan Syndrome or Related Phenotypes and FBN1 Mutations: An International Study. Am. J. Hum. Genet. 2007;81:454–466. doi: 10.1086/520125. - DOI - PMC - PubMed
    1. Neptune E.R., Frischmeyer P.A., Arking D.E., Myers L., Bunton T.E., Gayraud B., Ramirez F., Sakai L.Y., Dietz H.C. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 2003;33:407–411. doi: 10.1038/ng1116. - DOI - PubMed
    1. Loeys B.L., Chen J., Neptune E.R., Judge D.P., Podowski M., Holm T., Meyers J., Leitch C.C., Katsanis N., Sharifi N., et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 2005;37:275–281. doi: 10.1038/ng1511. - DOI - PubMed
    1. Van Hemelrijk C., Renard M., Loeys B. The Loeys–Dietz syndrome: An update for the clinician. Curr. Opin. Cardiol. 2010;25:546–551. doi: 10.1097/HCO.0b013e32833f0220. - DOI - PubMed

MeSH terms

LinkOut - more resources